Optimizing radionuclide imaging in the assessment of cardiac sarcoidosis

Journal of Nuclear Cardiology

Volumn 23, Issue 2, 2016, Pages 253-255

  Bois, John P ^a   Chareonthaitawee, Panithaya ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM; HEPARIN; RADIOISOTOPE;

CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; DIAGNOSTIC ACCURACY; DRUG UPTAKE; ECHOCARDIOGRAPHY; EDITORIAL; GLUCOSE UTILIZATION; HEART MUSCLE BIOPSY; HUMAN; LONG TERM SURVIVAL; PATIENT EDUCATION; PHOTON EMISSION TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOIDOSIS; SCINTISCANNING; CARDIOMYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING;

CARDIOMYOPATHIES; HUMANS; MAGNETIC RESONANCE IMAGING; RADIOISOTOPES; SARCOIDOSIS;

EID: 84960400170     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-015-0252-y     Document Type: Editorial

References (21)

1. Silverman KJ, Hutchins GM, Bulkey BH. Cardiac sarcoid: A clinicopathologic study of 84 unselected patietns with systemic sarcoidosis. Circulation 1978;58:1204-11.
2. Doughan AR, Williams BR. Cardiac sarcoidosis. Heart 2006;92:282-8.
3. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001;88:1006-10.
4. Cooper LT, Baughman K, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease. Circulation 2007;1216:2216-33.
5. Mañá J, Gámez C. Molecular imaging in sarcoidosis. Curr Opin Pulm Med 2011;17:325-31.
6. Ohira H, Tsujino I, Yoshinaga K, et al. 18F-fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging 2011;38:1773-83.
7. Youssef G, Leung E, Mylonas I, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: A systemic review and meta-analysis including the Ontario experience. J Nucl Med 2012;52:241-8.
8. Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1304-23.
9. Manabe O, Ohira H, Yoshinaga K, et al. Elevated 18F-flurodexoyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis. Eur J Nucl Med Mol Imaging 2013;40:1558-66.
10. Maurer AH, Burshteyn M, Adler LP, Steiner RM. How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET/CT. RadioGraphics 2011;31:1287-305.
11. Ishida Y, Yoshinaga K, Miyagawa M, et al. Recommendations for F-Flurodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology Reccomendations. Ann Nucl Med 2014;28:393-403.
12. Newsholme P, Newsholme EA. Rates of utilization of glucose, glutamine and oleate and formation of end-products by mouse peritoneal macro. Biochem J 1989;261:211-8.
13. Williams G, Kolodny G. Suppression of myocardial 18F-FDG uptake by preparing patients with high-fat, low-carbohydrate diet. Am J Roentgenol 2008;190:W151-6.
14. Ito K, Morooka M, Okazaki O. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity. Clin Nucl Med 2013;38:128-30.
15. Maurer AH, Burshteyn M, Adler LP, Gaughan JP, Steiner RM. Variable cardiac 18 FDG patterns seen in oncologic positron emission tomography computed tomography importance for differentiating normal physiology from cardiac and paracardiac disease. J Thorac Imaging 2012;27:263-8.
16. Morooka M, Moroi M, Ito K, et al. Heparin vs. long fasting method: Which inhibits the FDG myocardial physiological uptake more strongly? J Nucl Med 2013;54:406.
17. Kyrtatos PG, Constandinou N, Loizides S, Mumtaz T. Improved patient education facilitates adherence to preoperative fasting guidelines. J Perioper Pract 2014;24:228-31.
18. Nadella V, Gupta M, Brown J, et al. Evaluation of adherence to recommended fasting guidelines in pediatric surgery in a teaching hospital in the UK: 10AP3-3. Eur J Anaesthesiol 2013;30:162-3.
19. Cheng VY, Slomka P, Ahlen M, et al. Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: A randomized controlled trial. J Nucl Cardiol 2010;17:286-91.
20. Kobayashi Y, Kumita S, Fukushima Y. Significant suppression of myocardial 18F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet. J Cardiol 2013;62:314-9.
21. Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with 12N-NH 3/18F-FDG PET. J Nucl Med 2003;44:1030-6.